Her cancer is being treated with 10 different chemotherapies.
But she isn't.
By testing multiple chemotherapies on a patient's cancer cells before treating a cancer patient, ChemoFx®
helps determine the chemotherapies that are more likely to be effective and helps guide the physician away from therapies that are more likely to be ineffective- giving patients a powerful advantage in the fight against gynecologic cancer.
What is ChemoFx?
is a drug response marker. It's a test that quantifies an individual gynecologic cancer patient's probable tumor response to various chemotherapeutic and biologic agents—providing both sensitivity and resistance information. While not intended to replace standard of care, ChemoFx®
provides valuable insights that help guide physicians' treatment decisions and give both physicians and patients an edge against gynecologic cancer.